Avon realignment
This article was originally published in The Rose Sheet
Executive Summary
In line with recently announced restructuring initiative, which includes bringing senior management "closer to its key business geographies," Avon will now manage Central and Eastern Europe and China as stand-alone business units "due to their strategic importance and long-term growth potential," firm announces Dec. 7. Consequently, Avon has appointed Senior VP, Asia Pacific Bennett Gallina to new role as senior VP overseeing China, as well as Western Europe, Middle East and Africa business units. John Higson, currently area VP, Central and Eastern Europe, will be promoted to senior VP for Central and Eastern Europe, firm notes. Company also promotes James Wei to senior VP, Asia Pacific, from his current role as VP, new markets and strategic planning for Asia Pacific. Additionally, Avon will now manage its Brand Marketing and Supply Chain functions as unified Global Business Units, with new positions overseeing those divisions. All appointments are effective Jan. 1. Avon announced its restructuring plan last month (1"The Rose Sheet" Nov. 21, 2005, p. 3)...
You may also be interested in...
Avon Restructuring Initiative Aimed At Restoring Growth
Avon will launch several new skin care and color cosmetics initiatives next year and significantly increase advertising investment in an effort to restore competitiveness and drive revenue growth, according to CEO Andrea Jung
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.